Prescia Health

Prescia Health sits at the intersection of digital health, cognitive neuroscience, clinical research, and neurotechnology. Its MindMetrics platform is described as combining behavioural tasks with computational modelling and optional mobile EEG, positioning its approach around multidimensional brain-and-behaviour assessment rather than a single measurement modality. The company says its tools translate computational psychiatry research into assessments intended for real-world research and care, and reports deployments across four continents. The available details therefore support a description of Prescia’s niche and technical differentiation, but not a definitive assessment of market share or relative performance. Its single identified grant—CAD 100,000 from Ontario Brain Institute, announced Sep 24, 2026—also indicates an early funding profile rather than a large, extensively financed competitive position.

Its funding history consists of one grant: CAD 100,000 from Ontario Brain Institute, announced on Sep 24, 2026, equivalent to approximately USD 70,918. That grant is a concrete financing milestone, though it does not by itself establish the company’s operating scale or future funding prospects. Product-wise, the company is developing MindMetrics, which brings together behavioural tasks and computational modelling, with optional mobile EEG. The described deployment footprint across four continents suggests research use beyond a single local setting, but no deployment counts, dates, or named sites are provided. Company materials also describe a planned CAMH Emergency Department workflow evaluation, without a timeline or reported results. Five patent applications across two patent families indicate an effort to protect aspects of its work, although granted patents are not identified. Overall, the evidence suggests a research-led trajectory with a defined assessment platform and early external support; commercial traction and the pace of expansion remain unclear.